SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior - 2Top 10 Arising Advances That Will Shape What's in store
- 3Holiday weather forecast: Where travelers can expect a wintry mix, flooding and record warmth across the U.S.
- 4Tech for Learning: Online Courses and Instructive Apparatuses
- 5Zelensky names spy chief to head presidential office after corruption row
- Like many holiday traditions, lighting candles and fireplaces is best done in moderation
- What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve.
- IDF destroys Hamas shaft in northern Gaza with loaded 'ready to fire' rocket aimed at Sderot
- Nutrient Rich Organic products: Lift Your Wellbeing
- Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- EU delays signing of Mercosur free trade deal
- Congo declares its latest Ebola outbreak over, after 43 deaths
- Central African Republic's president sworn in for a third term after disputed election
- FOX8 Meteorologist Charles Ewing makes his 2025-26 winter weather predictions!
